Articles by Gregg Brandyberry - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Gregg Brandyberry

Gregg Brandyberry


a partner of Wildfire Commerce, senior advisor of AT Kearney procurement and analytic solutions, and former vice-president of procurement, global systems, and operations for GlaxoSmithKline, 629 Overhill Road, Ardmore, PA 19003, tel. 215.327.5739

Articles
Creating a Holistic Procurement System
December 5, 2012

The procurement organization rethinks sourcing for maximum efficiency and results.

Creating a Holistic Procurement System
November 2, 2012

The procurement organization rethinks sourcing for maximum efficiency and results.

Reflecting on 35 Years of Procurement Transformation
July 2, 2012

The past three decades have driven a purchasing evolution to a procurement revolution.

Ways to Recover Lost Margins
May 2, 2012

Recovery audits and other past practices in procurement can improve the bottom line.

Ways to Recover Lost Margins
April 2, 2012

Recovery audits and other past practices in procurement can improve the bottom line.

Offsetting Budget Cuts
August 4, 2011

Better strategies and practices in sourcing and procurement can contribute to the bottom line.

Offsetting Budget Cuts
July 2, 2011

Better strategies and practices in sourcing and procurement can contribute to the bottom line.

A Hard Look at Third-Party External Supply Networks
May 4, 2011

The complexity of third-party external supply networks requires new ways to manage them.

A Hard Look at Third-Party External Supply Networks
April 2, 2011

The complexity of third-party external supply networks requires new ways to manage them.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here